Company Overview
About Tandem
Tandem is a specialty drug access automation platform that has reached a $1 billion valuation in 2026, providing AI-powered automation of the full specialty pharmaceutical access workflow for healthcare providers — prior authorization submissions, access barrier management, copay assistance enrollment, and patient assistance program identification. The platform targets the $500+ billion specialty drug market where access friction is the primary barrier preventing patients from receiving prescribed medications.
Business Model & Competitive Advantage
Specialty drugs (biologics, gene therapies, specialty injectables) are among the most administratively complex prescriptions in healthcare: each requires insurance prior authorization, often multiple appeals, manufacturer assistance program enrollment, specialty pharmacy coordination, and ongoing monitoring requirements. The average specialty drug access workflow requires 19+ manual steps across provider office staff, payer systems, and specialty pharmacies — steps that Tandem automates into a streamlined digital workflow.
Competitive Landscape 2025–2026
The $1B valuation reflects the urgency of the specialty drug access problem: as GLP-1 medications, cancer immunotherapies, and rare disease biologics proliferate at $50,000-$500,000+ per year price points, the access workflow bottleneck directly determines whether patients receive life-changing or life-saving treatments. Providers who deploy Tandem can dramatically increase the percentage of prescribed specialty drugs that patients actually fill.
Open Positions
Reddit Discussions
Key Differentiators
Strong Challenger
Tandem is an established challenger with significant market presence and competitive offerings in Digital Health.
Enterprise Scale
With $1000M in revenue, Tandem operates at enterprise scale with proven market validation.
Frequently Asked Questions
Not So Random Others
Oura
Oura is the maker of the Oura Ring, a premium smart ring that tracks sleep, recovery, readiness, and health metrics through continuous biometric sensing. The company raised $900 million in Series E fi
a2z Radiology AI
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disea
Honda
Honda Motor Co., Ltd. is a Japanese multinational mobility conglomerate founded in 1948 by Soichiro Honda and Takeo Fujisawa in Hamamatsu, Japan. Starting as a motorcycle manufacturer, Honda expanded
Hyundai
Hyundai Motor Company was founded in 1967 in Seoul, South Korea, by Chung Ju-yung and has grown into one of the world's largest automotive manufacturers, ranking third globally by vehicle sales. From
Benchling
Benchling is a cloud-based research and development platform purpose-built for the life sciences industry, founded in 2012 by Sajith Wickramasekara and Ashu Singhal as a Y Combinator alumnus. The comp
Tesla
Tesla is an electric vehicle and clean energy company founded in 2003 by Martin Eberhard and Marc Tarpenning in San Carlos, California, and subsequently co-founded and led by Elon Musk, who joined as
Compare Tandem with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Tandem? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Tandem Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Tandem vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →